You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
賢豐控股(002141.SZ)擬3.57億元購買成都天邦和南京史紀各70%股權
格隆匯 03-15 20:47

格隆匯 3 月 15日丨賢豐控股(002141.SZ)公佈,2021年3月15日公司第七屆董事會第五次會議審議通過了《關於收購股權暨對外投資的議案》,公司擬通過支付現金的方式向天邦食品股份有限公司下屬全資子公司史記生物技術(南京)有限公司購買其持有的成都天邦生物製品有限公司70%股權和南京史紀生物科技有限公司70%股權,交易價格分別為人民幣3.22億元、3500萬元,並提請股東大會授權公司管理層辦理此次收購股權暨對外投資的具體事宜。、

公司看好動物疫苗行業未來發展前景,因此,公司擬通過併購產品成熟、業務體系相對完整的、研發實力較強的標的資產能夠快速實現切入該行業,為公司培養新的利潤增長點。公司此次交易的資金來源主要為經營性自有資金及對外投資迴流資金,必要時以適當增加負債的形式籌措資金完成支付,經測算相關支出不會影響公司正常生產經營。如此次交易的推進情況符合預期,預計對公司本期和未來財務狀況和經營成果將產生較為積極的影響。

此次交易完成後,成都天邦和南京史紀將成為公司控股子公司,納入公司合併財務報表範圍,此次交易將按照非同一控制下企業合併的規定進行初始會計處理,合併日前成都天邦和南京史紀的損益不影響公司經營業績。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account